Africans are now just as keen on Asian medicine: artemisinin, a highly effective malaria remedy derived from a Chinese shrub.

非洲人现在同样热衷于亚洲药物：青蒿素，一种从中国灌木中提取的、非常有效的治疗疟疾的药物。

The groups have also invested in antimalaria drugs for A.C.T., artemisinin-based combination therapy.

这些组织也投资于抗疟疾药物开发，基于青蒿素的组合疗法。

Artemisinin is also a promising potent drug in the treatment of cancer, human parasites such as pneumocystosis.

青蒿素还是一种有前途的有效药物，可用于治疗癌症，人类寄生虫，如肺囊虫病。

Why artemisinin resistance occurs.

青蒿素耐药性出现的原因。

Containing the spread of artemisinin resistance.

控制青蒿素耐药性的扩散。

The emergence of artemisinin resistance has been a wake-up call.

青蒿素耐药性的出现敲响了警钟。

We have highly effective artemisinin-based combination therapies.

我们有高度有效的以青蒿素为基础的联合疗法。

Q: What made you and your team think of using artemisinin to treat malaria?

问：您和您的团队怎么会想到用青蒿素治疗疟疾呢？

Treatment: the use of artemisinin combination therapy to treat malaria.

治疗：使用青蒿素联合疗法治疗疟疾。

These combinations are called artemisinin-based combination therapies (ACTs).

这种联合被称为以青蒿素为基础的联合化疗（ACTs）。

Before, we were warning people that there could be an emergence of artemisinin resistance.

此前，我们向人们警告对青蒿素的耐药性可能出现。

Scientists continue to investigate how and why artemisinin resistance specifically emerges.

科学家在继续调查青蒿素耐药性具体出现的方式和原因。

After harvesting or collection, the artemisinin content of the leaves will gradually decrease.

在收获或采收之后，叶中的青蒿素含量将逐步减少。

Monotherapies are therefore the primary force behind the spread of artemisinin resistance.

因此，单方疗法是造成对青蒿素耐药性扩散的主要因素。

Since then, the world market for products containing artemisinin derivatives has grown rapidly.

自那时以来，含青蒿素衍生物的产品的世界市场已迅速扩大。

This failure is due to resistance to artemisinin, our best and last class of effective antimalarials.

这是因为对最佳，也是最后一类有效抗疟药——青蒿素，产生耐药性所导致的失败。

The arrival of artemisinin a few years ago raised hopes, but big obstacles to its widespread use remain.

几年前引进的青蒿素又给人们带来了希望，但对于这种药物的广泛使用还有不少障碍。

Artemisinin derivatives are not inferior to quinine in preventing death in children with cerebral malaria.

在防止脑型疟疾患儿死亡青蒿素衍生物并不次于奎宁。

We clearly mentioned others such as [contemporary artemisinin researchers] Yu Yagang and Zhong Yurong.

我们清楚地提到其他人比如余亚刚、钟裕容。

In February 2009, WHO confirmed that resistance to artemisinin had emerged on the Cambodia-Thailand border.

在2009年2月，世卫组织证实在柬埔寨和泰国边界已出现对青蒿素的耐药性。

They helped improve the fixed combination by replacing artemisinin with [one of its derivatives], artemether.

他们用青蒿素的一种衍生物——蒿甲醚代替青蒿素，协助改进了固定复方药。

Q: Why did you research ACT for malaria at a time when there were no concerns about resistance to artemisinin?

问：为何您在青蒿素耐药性并未引起关注的时候就研究青蒿素类复方药呢？

More comprehensive recommendations are available in the Global Plan for Artemisinin Resistance Containment (GPARC).

《控制青蒿素耐药性全球计划》中载有更全面的建议。